Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 70

1.

Preformed Donor-Specific HLA Antibodies in Living and Deceased Donor Transplantation: A Multicenter Study.

Ziemann M, Altermann W, Angert K, Arns W, Bachmann A, Bakchoul T, Banas B, von Borstel A, Budde K, Ditt V, Einecke G, Eisenberger U, Feldkamp T, Görg S, Guthoff M, Habicht A, Hallensleben M, Heinemann FM, Hessler N, Hugo C, Kaufmann M, Kauke T, Koch M, König IR, Kurschat C, Lehmann C, Marget M, Mühlfeld A, Nitschke M, Pego da Silva L, Quick C, Rahmel A, Rath T, Reinke P, Renders L, Sommer F, Spriewald B, Staeck O, Stippel D, Süsal C, Thiele B, Zecher D, Lachmann N.

Clin J Am Soc Nephrol. 2019 Jul 5;14(7):1056-1066. doi: 10.2215/CJN.13401118. Epub 2019 Jun 18.

PMID:
31213508
2.

Generating automated kidney transplant biopsy reports combining molecular measurements with ensembles of machine learning classifiers.

Reeve J, Böhmig GA, Eskandary F, Einecke G, Gupta G, Madill-Thomsen K, Mackova M, Halloran PF; INTERCOMEX MMDx-Kidney Study Group.

Am J Transplant. 2019 Mar 13. doi: 10.1111/ajt.15351. [Epub ahead of print]

PMID:
30868758
3.

Renal transplant recipients receiving loop diuretic therapy have increased urinary tract infection rate and altered medullary macrophage polarization marker expression.

Casper J, Schmitz J, Bräsen JH, Khalifa A, Schmidt BMW, Einecke G, Haller H, von Vietinghoff S.

Kidney Int. 2018 Nov;94(5):993-1001. doi: 10.1016/j.kint.2018.06.029. Epub 2018 Sep 28.

PMID:
30274681
4.

Fatal Pneumococcus Sepsis after Treatment of Late Antibody-Mediated Kidney Graft Rejection.

Einecke G, Bräsen JH, Hanke N, Haller H, Schwarz A.

Case Rep Nephrol. 2018 Feb 28;2018:1415450. doi: 10.1155/2018/1415450. eCollection 2018.

5.

Therapeutic plasma exchange in a tertiary care center: 185 patients undergoing 912 treatments - a one-year retrospective analysis.

Schmidt JJ, Asper F, Einecke G, Eden G, Hafer C, Kielstein JT.

BMC Nephrol. 2018 Jan 15;19(1):12. doi: 10.1186/s12882-017-0803-3.

6.

Review: The transcripts associated with organ allograft rejection.

Halloran PF, Venner JM, Madill-Thomsen KS, Einecke G, Parkes MD, Hidalgo LG, Famulski KS.

Am J Transplant. 2018 Apr;18(4):785-795. doi: 10.1111/ajt.14600. Epub 2017 Dec 23. Review.

7.

A molecular biopsy test based on arteriolar under-hyalinosis reflects increased probability of rejection related to under-immunosuppression.

Einecke G, Reeve J, Halloran PF.

Am J Transplant. 2018 Apr;18(4):821-831. doi: 10.1111/ajt.14532. Epub 2017 Nov 10.

8.

Assessing rejection-related disease in kidney transplant biopsies based on archetypal analysis of molecular phenotypes.

Reeve J, Böhmig GA, Eskandary F, Einecke G, Lefaucheur C, Loupy A, Halloran PF; MMDx-Kidney study group.

JCI Insight. 2017 Jun 15;2(12). pii: 94197. doi: 10.1172/jci.insight.94197. eCollection 2017 Jun 15.

9.

Real Time Central Assessment of Kidney Transplant Indication Biopsies by Microarrays: The INTERCOMEX Study.

Halloran PF, Reeve J, Akalin E, Aubert O, Bohmig GA, Brennan D, Bromberg J, Einecke G, Eskandary F, Gosset C, Duong Van Huyen JP, Gupta G, Lefaucheur C, Malone A, Mannon RB, Seron D, Sellares J, Weir M, Loupy A.

Am J Transplant. 2017 Nov;17(11):2851-2862. doi: 10.1111/ajt.14329. Epub 2017 May 30.

10.

Macrophage density in early surveillance biopsies predicts future renal transplant function.

Bräsen JH, Khalifa A, Schmitz J, Dai W, Einecke G, Schwarz A, Hallensleben M, Schmidt BMW, Kreipe HH, Haller H, von Vietinghoff S.

Kidney Int. 2017 Aug;92(2):479-489. doi: 10.1016/j.kint.2017.01.029. Epub 2017 Mar 27.

PMID:
28359537
11.

The answer is blowing in the wind: an uncommon cause for severe ARDS accompanied by circulatory insufficiency requiring extracorporeal membrane oxygenation.

Einecke G, Beutel G, Hoeper MM, Kielstein JT.

BMJ Case Rep. 2017 Mar 24;2017. pii: bcr2016218079. doi: 10.1136/bcr-2016-218079.

12.

Hyalinosis Lesions in Renal Transplant Biopsies: Time-Dependent Complexity of Interpretation.

Einecke G, Reeve J, Halloran PF.

Am J Transplant. 2017 May;17(5):1346-1357. doi: 10.1111/ajt.14136. Epub 2017 Jan 3.

13.

Ultrasound findings in EHEC-associated hemolytic-uremic syndrome and their clinical relevance.

Reising A, Hafer C, Hiss M, Kielstein JT, Menne J, Gueler F, Beneke J, Linnenweber-Held S, Haller H, Einecke G.

Int Urol Nephrol. 2016 Apr;48(4):561-70. doi: 10.1007/s11255-015-1194-7. Epub 2016 Jan 12.

PMID:
26759326
14.

Determination of unacceptable HLA antigen mismatches in kidney transplant recipients: recommendations of the German Society for Immunogenetics.

Süsal C, Seidl C, Schönemann C, Heinemann FM, Kauke T, Gombos P, Kelsch R, Arns W, Bauerfeind U, Hallensleben M, Hauser IA, Einecke G, Blasczyk R.

Tissue Antigens. 2015 Nov;86(5):317-23. doi: 10.1111/tan.12682. Review.

PMID:
26467895
15.

Disappearance of T Cell-Mediated Rejection Despite Continued Antibody-Mediated Rejection in Late Kidney Transplant Recipients.

Halloran PF, Chang J, Famulski K, Hidalgo LG, Salazar ID, Merino Lopez M, Matas A, Picton M, de Freitas D, Bromberg J, Serón D, Sellarés J, Einecke G, Reeve J.

J Am Soc Nephrol. 2015 Jul;26(7):1711-20. doi: 10.1681/ASN.2014060588. Epub 2014 Nov 6.

16.

Microarray diagnosis of antibody-mediated rejection in kidney transplant biopsies: an international prospective study (INTERCOM).

Halloran PF, Pereira AB, Chang J, Matas A, Picton M, De Freitas D, Bromberg J, Serón D, Sellarés J, Einecke G, Reeve J.

Am J Transplant. 2013 Nov;13(11):2865-74. doi: 10.1111/ajt.12465. Epub 2013 Oct 3.

17.

Potential impact of microarray diagnosis of T cell-mediated rejection in kidney transplants: The INTERCOM study.

Halloran PF, Pereira AB, Chang J, Matas A, Picton M, De Freitas D, Bromberg J, Serón D, Sellarés J, Einecke G, Reeve J.

Am J Transplant. 2013 Sep;13(9):2352-63. doi: 10.1111/ajt.12387. Epub 2013 Aug 5.

18.

Mycobacterium intracellulare bacteraemia in a double lung transplant patient.

Suhling H, Einecke G, Rademacher J, Welte T, Suerbaum S, Warnecke G, Gottlieb J, Bange FC.

Int J Tuberc Lung Dis. 2012 Dec;16(12):1710-1. doi: 10.5588/ijtld.12.0422. No abstract available.

PMID:
23131276
19.

Molecular phenotypes of acute kidney injury in kidney transplants.

Famulski KS, de Freitas DG, Kreepala C, Chang J, Sellares J, Sis B, Einecke G, Mengel M, Reeve J, Halloran PF.

J Am Soc Nephrol. 2012 May;23(5):948-58. doi: 10.1681/ASN.2011090887. Epub 2012 Feb 16.

20.

Understanding the causes of kidney transplant failure: the dominant role of antibody-mediated rejection and nonadherence.

Sellarés J, de Freitas DG, Mengel M, Reeve J, Einecke G, Sis B, Hidalgo LG, Famulski K, Matas A, Halloran PF.

Am J Transplant. 2012 Feb;12(2):388-99. doi: 10.1111/j.1600-6143.2011.03840.x. Epub 2011 Nov 14.

21.

The nature of biopsies with "borderline rejection" and prospects for eliminating this category.

de Freitas DG, Sellarés J, Mengel M, Chang J, Hidalgo LG, Famulski KS, Sis B, Einecke G, Halloran PF.

Am J Transplant. 2012 Jan;12(1):191-201. doi: 10.1111/j.1600-6143.2011.03784.x. Epub 2011 Oct 12.

22.

The molecular phenotype of 6-week protocol biopsies from human renal allografts: reflections of prior injury but not future course.

Mengel M, Chang J, Kayser D, Gwinner W, Schwarz A, Einecke G, Broecker V, Famulski K, de Freitas DG, Guembes-Hidalgo L, Sis B, Haller H, Halloran PF.

Am J Transplant. 2011 Apr;11(4):708-18. doi: 10.1111/j.1600-6143.2010.03339.x. Epub 2010 Nov 29.

23.

An integrated view of molecular changes, histopathology and outcomes in kidney transplants.

Halloran PF, de Freitas DG, Einecke G, Famulski KS, Hidalgo LG, MengeL M, Reeve J, Sellares J, Sis B.

Am J Transplant. 2010 Oct;10(10):2223-30.

PMID:
20931696
24.

The molecular phenotype of kidney transplants.

Halloran PF, de Freitas DG, Einecke G, Famulski KS, Hidalgo LG, Mengel M, Reeve J, Sellares J, Sis B.

Am J Transplant. 2010 Oct;10(10):2215-22.

PMID:
20931695
25.

Loss of solute carriers in T cell-mediated rejection in mouse and human kidneys: an active epithelial injury-repair response.

Einecke G, Kayser D, Vanslambrouck JM, Sis B, Reeve J, Mengel M, Famulski KS, Bailey CG, Rasko JE, Halloran PF.

Am J Transplant. 2010 Oct;10(10):2241-51. doi: 10.1111/j.1600-6143.2010.03263.x.

26.

The molecular phenotype of heart transplant biopsies: relationship to histopathological and clinical variables.

Mengel M, Sis B, Kim D, Chang J, Famulski KS, Hidalgo LG, Einecke G, de Freitas DG, Tymchak W, Burton J, Halloran PF.

Am J Transplant. 2010 Sep;10(9):2105-15. doi: 10.1111/j.1600-6143.2010.03182.x.

27.

NK cell transcripts and NK cells in kidney biopsies from patients with donor-specific antibodies: evidence for NK cell involvement in antibody-mediated rejection.

Hidalgo LG, Sis B, Sellares J, Campbell PM, Mengel M, Einecke G, Chang J, Halloran PF.

Am J Transplant. 2010 Aug;10(8):1812-22. doi: 10.1111/j.1600-6143.2010.03201.x.

28.

A molecular classifier for predicting future graft loss in late kidney transplant biopsies.

Einecke G, Reeve J, Sis B, Mengel M, Hidalgo L, Famulski KS, Matas A, Kasiske B, Kaplan B, Halloran PF.

J Clin Invest. 2010 Jun;120(6):1862-72. doi: 10.1172/JCI41789. Epub 2010 May 24.

29.

Defining the canonical form of T-cell-mediated rejection in human kidney transplants.

Famulski KS, Einecke G, Sis B, Mengel M, Hidalgo LG, Kaplan B, Halloran PF.

Am J Transplant. 2010 Apr;10(4):810-20. doi: 10.1111/j.1600-6143.2009.03007.x. Epub 2010 Feb 3.

30.

Alternative macrophage activation-associated transcripts in T-cell-mediated rejection of mouse kidney allografts.

Famulski KS, Kayser D, Einecke G, Allanach K, Badr D, Venner J, Sis B, Halloran PF.

Am J Transplant. 2010 Mar;10(3):490-7. doi: 10.1111/j.1600-6143.2009.02983.x. Epub 2010 Jan 29.

31.

Banff '09 meeting report: antibody mediated graft deterioration and implementation of Banff working groups.

Sis B, Mengel M, Haas M, Colvin RB, Halloran PF, Racusen LC, Solez K, Baldwin WM 3rd, Bracamonte ER, Broecker V, Cosio F, Demetris AJ, Drachenberg C, Einecke G, Gloor J, Glotz D, Kraus E, Legendre C, Liapis H, Mannon RB, Nankivell BJ, Nickeleit V, Papadimitriou JC, Randhawa P, Regele H, Renaudin K, Rodriguez ER, Seron D, Seshan S, Suthanthiran M, Wasowska BA, Zachary A, Zeevi A.

Am J Transplant. 2010 Mar;10(3):464-71. doi: 10.1111/j.1600-6143.2009.02987.x. Epub 2010 Jan 29.

32.

Cluster analysis of lesions in nonselected kidney transplant biopsies: microcirculation changes, tubulointerstitial inflammation and scarring.

Sis B, Einecke G, Chang J, Hidalgo LG, Mengel M, Kaplan B, Halloran PF.

Am J Transplant. 2010 Feb;10(2):421-30. doi: 10.1111/j.1600-6143.2009.02938.x. Epub 2010 Jan 6.

33.

De novo donor-specific antibody at the time of kidney transplant biopsy associates with microvascular pathology and late graft failure.

Hidalgo LG, Campbell PM, Sis B, Einecke G, Mengel M, Chang J, Sellares J, Reeve J, Halloran PF.

Am J Transplant. 2009 Nov;9(11):2532-41. doi: 10.1111/j.1600-6143.2009.02800.x.

34.

Antibody-mediated microcirculation injury is the major cause of late kidney transplant failure.

Einecke G, Sis B, Reeve J, Mengel M, Campbell PM, Hidalgo LG, Kaplan B, Halloran PF.

Am J Transplant. 2009 Nov;9(11):2520-31. doi: 10.1111/j.1600-6143.2009.02799.x.

35.

Scoring total inflammation is superior to the current Banff inflammation score in predicting outcome and the degree of molecular disturbance in renal allografts.

Mengel M, Reeve J, Bunnag S, Einecke G, Jhangri GS, Sis B, Famulski K, Guembes-Hidalgo L, Halloran PF.

Am J Transplant. 2009 Aug;9(8):1859-67. doi: 10.1111/j.1600-6143.2009.02727.x. Epub 2009 Jun 26.

36.

Diagnosing rejection in renal transplants: a comparison of molecular- and histopathology-based approaches.

Reeve J, Einecke G, Mengel M, Sis B, Kayser N, Kaplan B, Halloran PF.

Am J Transplant. 2009 Aug;9(8):1802-10. doi: 10.1111/j.1600-6143.2009.02694.x. Epub 2009 Jun 10.

37.

Molecular correlates of renal function in kidney transplant biopsies.

Bunnag S, Einecke G, Reeve J, Jhangri GS, Mueller TF, Sis B, Hidalgo LG, Mengel M, Kayser D, Kaplan B, Halloran PF.

J Am Soc Nephrol. 2009 May;20(5):1149-60. doi: 10.1681/ASN.2008080863. Epub 2009 Apr 23.

38.

The early course of kidney allograft rejection: defining the time when rejection begins.

Einecke G, Mengel M, Hidalgo L, Allanach K, Famulski KS, Halloran PF.

Am J Transplant. 2009 Mar;9(3):483-93. doi: 10.1111/j.1600-6143.2008.02546.x.

39.

Molecular correlates of scarring in kidney transplants: the emergence of mast cell transcripts.

Mengel M, Reeve J, Bunnag S, Einecke G, Sis B, Mueller T, Kaplan B, Halloran PF.

Am J Transplant. 2009 Jan;9(1):169-78. doi: 10.1111/j.1600-6143.2008.02462.x. Epub 2008 Oct 31.

40.

Gene-set analysis and reduction.

Dinu I, Potter JD, Mueller T, Liu Q, Adewale AJ, Jhangri GS, Einecke G, Famulski KS, Halloran P, Yasui Y.

Brief Bioinform. 2009 Jan;10(1):24-34. doi: 10.1093/bib/bbn042. Epub 2008 Oct 4. Review.

41.

Donor Fas is not necessary for T-cell-mediated rejection of mouse kidney allografts.

Kayser D, Einecke G, Famulski KS, Mengel M, Sis B, Zhu LF, Halloran PF.

Am J Transplant. 2008 Oct;8(10):2049-55. doi: 10.1111/j.1600-6143.2008.02375.x.

42.

FOXP3 expression in human kidney transplant biopsies is associated with rejection and time post transplant but not with favorable outcomes.

Bunnag S, Allanach K, Jhangri GS, Sis B, Einecke G, Mengel M, Mueller TF, Halloran PF.

Am J Transplant. 2008 Jul;8(7):1423-33. doi: 10.1111/j.1600-6143.2008.02268.x.

43.

Expression of B cell and immunoglobulin transcripts is a feature of inflammation in late allografts.

Einecke G, Reeve J, Mengel M, Sis B, Bunnag S, Mueller TF, Halloran PF.

Am J Transplant. 2008 Jul;8(7):1434-43. doi: 10.1111/j.1600-6143.2008.02232.x.

44.

Comparing microarray versus RT-PCR assessment of renal allograft biopsies: similar performance despite different dynamic ranges.

Allanach K, Mengel M, Einecke G, Sis B, Hidalgo LG, Mueller T, Halloran PF.

Am J Transplant. 2008 May;8(5):1006-15. doi: 10.1111/j.1600-6143.2008.02199.x.

45.

Banff 07 classification of renal allograft pathology: updates and future directions.

Solez K, Colvin RB, Racusen LC, Haas M, Sis B, Mengel M, Halloran PF, Baldwin W, Banfi G, Collins AB, Cosio F, David DS, Drachenberg C, Einecke G, Fogo AB, Gibson IW, Glotz D, Iskandar SS, Kraus E, Lerut E, Mannon RB, Mihatsch M, Nankivell BJ, Nickeleit V, Papadimitriou JC, Randhawa P, Regele H, Renaudin K, Roberts I, Seron D, Smith RN, Valente M.

Am J Transplant. 2008 Apr;8(4):753-60. doi: 10.1111/j.1600-6143.2008.02159.x. Epub 2008 Feb 19.

46.

The transcriptome of human cytotoxic T cells: measuring the burden of CTL-associated transcripts in human kidney transplants.

Hidalgo LG, Einecke G, Allanach K, Mengel M, Sis B, Mueller TF, Halloran PF.

Am J Transplant. 2008 Mar;8(3):637-46. doi: 10.1111/j.1600-6143.2007.02129.x.

47.

The transcriptome of human cytotoxic T cells: similarities and disparities among allostimulated CD4(+) CTL, CD8(+) CTL and NK cells.

Hidalgo LG, Einecke G, Allanach K, Halloran PF.

Am J Transplant. 2008 Mar;8(3):627-36. doi: 10.1111/j.1600-6143.2007.02128.x.

48.

A biological evaluation of six gene set analysis methods for identification of differentially expressed pathways in microarray data.

Dinu I, Liu Q, Potter JD, Adewale AJ, Jhangri GS, Mueller T, Einecke G, Famulsky K, Halloran P, Yasui Y.

Cancer Inform. 2008;6:357-68. Epub 2008 Jun 20.

49.

Microarray analysis of rejection in human kidney transplants using pathogenesis-based transcript sets.

Mueller TF, Einecke G, Reeve J, Sis B, Mengel M, Jhangri GS, Bunnag S, Cruz J, Wishart D, Meng C, Broderick G, Kaplan B, Halloran PF.

Am J Transplant. 2007 Dec;7(12):2712-22. Epub 2007 Oct 17.

50.

Transcriptome analysis reveals heterogeneity in the injury response of kidney transplants.

Famulski KS, Broderick G, Einecke G, Hay K, Cruz J, Sis B, Mengel M, Halloran PF.

Am J Transplant. 2007 Nov;7(11):2483-95. Epub 2007 Oct 1.

Supplemental Content

Loading ...
Support Center